Tue, June 11, 2024

Patrick Trucchio Reiterated (ARWR) at Strong Buy and Held Target at $90 on, Jun 11th, 2024

Patrick Trucchio of HC Wainwright & Co., Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $90 on, Jun 11th, 2024.

Patrick has made no other calls on ARWR in the last 4 months.



There are 3 other peers that have a rating on ARWR. Out of the 3 peers that are also analyzing ARWR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


This is the rating of the analyst that currently disagrees with Patrick


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Monday, June 3rd, 2024